mutations and complicated kar yotype. It follows a linear evolution with the CLL clone from the recurrent acquisition of CDKN2A??? "???????????????????????????????????????????????"??????????????? ?????????????????????????Mortality danger amongst hospitalized clients with BSI was improved amongst Individuals with carbapenem resistance, with the best